USD 42.44
(1.05%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 10.63 Billion ZAR | 29.2% |
2023 | 9.31 Billion ZAR | 10.46% |
2022 | 8.43 Billion ZAR | 15.96% |
2021 | 7.27 Billion ZAR | 0.88% |
2020 | 7.2 Billion ZAR | 7.75% |
2019 | 6.69 Billion ZAR | 8.3% |
2018 | 6.17 Billion ZAR | 9.84% |
2017 | 5.62 Billion ZAR | 12.16% |
2016 | 5.01 Billion ZAR | 10.82% |
2015 | 4.52 Billion ZAR | 9.73% |
2014 | 4.12 Billion ZAR | 9.01% |
2013 | 3.78 Billion ZAR | 8.84% |
2012 | 3.47 Billion ZAR | 7.81% |
2011 | 3.22 Billion ZAR | 11.03% |
2010 | 2.9 Billion ZAR | 15.34% |
2009 | 2.51 Billion ZAR | 13.86% |
2008 | 2.21 Billion ZAR | 16.47% |
2007 | 1.89 Billion ZAR | -2.83% |
2006 | 1.95 Billion ZAR | 14.28% |
2005 | 1.7 Billion ZAR | 11.18% |
2004 | 1.53 Billion ZAR | -14.14% |
2003 | 1.79 Billion ZAR | 15.14% |
2002 | 1.55 Billion ZAR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q4 | 339.42 Million USD | 0.0% |
2024 Q2 | 305.97 Million USD | 0.0% |
2023 FY | 9.31 Billion ZAR | 10.46% |
2023 Q4 | 304.25 Million USD | 0.0% |
2023 Q2 | 287.82 Million USD | 0.0% |
2022 FY | 8.43 Billion ZAR | 15.96% |
2022 Q4 | 332.85 Million USD | 0.0% |
2022 Q2 | 307.28 Million USD | 0.0% |
2021 Q4 | 306.68 Million USD | 0.0% |
2021 Q2 | 273.66 Million USD | 0.0% |
2021 FY | 7.27 Billion ZAR | 0.88% |
2020 Q4 | 240.48 Million USD | 0.0% |
2020 Q2 | 275.41 Million USD | 0.0% |
2020 FY | 7.2 Billion ZAR | 7.75% |
2019 FY | 6.69 Billion ZAR | 8.3% |
2019 Q4 | 291.03 Million USD | 0.0% |
2018 FY | 6.17 Billion ZAR | 9.84% |
2017 FY | 5.62 Billion ZAR | 12.16% |
2016 FY | 5.01 Billion ZAR | 10.82% |
2015 FY | 4.52 Billion ZAR | 9.73% |
2014 FY | 4.12 Billion ZAR | 9.01% |
2013 FY | 3.78 Billion ZAR | 8.84% |
2012 FY | 3.47 Billion ZAR | 7.81% |
2011 FY | 3.22 Billion ZAR | 11.03% |
2010 FY | 2.9 Billion ZAR | 15.34% |
2009 FY | 2.51 Billion ZAR | 13.86% |
2008 FY | 2.21 Billion ZAR | 16.47% |
2007 FY | 1.89 Billion ZAR | -2.83% |
2006 FY | 1.95 Billion ZAR | 14.28% |
2005 FY | 1.7 Billion ZAR | 11.18% |
2004 FY | 1.53 Billion ZAR | -14.14% |
2003 FY | 1.79 Billion ZAR | 15.14% |
2002 FY | 1.55 Billion ZAR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Alternative Energy Partners, Inc. | - USD | -Infinity% |
Allstar Health Brands, Inc. | - USD | -Infinity% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -7829.994% |
Café Serendipity Holdings, Inc. | 1196.00 USD | -888998144.147% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | - USD | -Infinity% |
HealthWarehouse.com, Inc. | 12.17 Million USD | -87237.699% |
LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -11978.726% |
MedGen, Inc. | 1.05 USD | -1012611333233.333% |
Omni Health, Inc. | 1.55 Million USD | -684738.938% |
Oxford Investments Holdings Inc. | 31.45 Thousand USD | -33798676.146% |
Pineapple, Inc. | -1.02 Million USD | 1037720.963% |
ScripsAmerica, Inc. | 27.59 Million USD | -38427.321% |